182 related articles for article (PubMed ID: 1719247)
1. Prostatic acid phosphatase, beta-glucuronidase and prostate specific antigen assays in fine needle aspirates from benign and malignant prostates.
Erickson DR; Hlavinka TC; Rockwood AP; Metter JD; Novicki DE; Fried MG
J Urol; 1991 Nov; 146(5):1402-7. PubMed ID: 1719247
[TBL] [Abstract][Full Text] [Related]
2. Deoxyribonucleic acid ploidy and the direct assay of prostatic acid phosphatase and prostate specific antigen in fine needle aspiration biopsies as diagnostic methods in prostatic carcinoma.
Stege R; Lundh B; Tribukait B; Pousette A; Carlström K; Hasenson M
J Urol; 1990 Aug; 144(2 Pt 1):299-302. PubMed ID: 1695689
[TBL] [Abstract][Full Text] [Related]
3. Prostatic acid phosphatase and prostate-specific antigen in prostate cancer.
Kuriyama M; Loor R; Wang MC; Lee C; Killian CS; Papsidero LD; Inaji H; Nishiura T; Slack NH; Murphy GP; Chu TM
Int Adv Surg Oncol; 1982; 5():29-49. PubMed ID: 6178696
[No Abstract] [Full Text] [Related]
4. Prostatic specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer.
Ercole CJ; Lange PH; Mathisen M; Chiou RK; Reddy PK; Vessella RL
J Urol; 1987 Nov; 138(5):1181-4. PubMed ID: 2444720
[TBL] [Abstract][Full Text] [Related]
5. Uses and limitations of prostate-specific antigen in the laboratory diagnosis of prostate cancer.
Wells DJ; Bennett BD; Gardner WA
South Med J; 1988 Feb; 81(2):218-20. PubMed ID: 2448884
[TBL] [Abstract][Full Text] [Related]
6. [Immunohistochemical determination of prostate-specific acid phosphatase (PSAP), prostate-specific antigen (PSA) and epithelial membrane antigen (EMA) with monoclonal antibodies in punch biopsies of the prostate].
Wacker U; Müller HA
Verh Dtsch Ges Pathol; 1986; 70():325-8. PubMed ID: 2435081
[No Abstract] [Full Text] [Related]
7. [Purification and enzyme immunoassay of tumor markers for prostate cancer: prostatic acid phosphatase, prostate-specific antigen and creatine kinase BB].
Morishita N; Minami Y; Ogawa S; Saito Y
Nihon Hinyokika Gakkai Zasshi; 1984 Mar; 75(3):404-13. PubMed ID: 6206268
[No Abstract] [Full Text] [Related]
8. The diagnostic value of urinary transferrin compared to serum prostatic specific antigen (PSA) and prostatic acid phosphatase (PAP) in patients with prostatic cancer.
van Dieijen-Visser MP; Hendriks MW; Delaere KP; Gijzen AH; Brombacher PJ
Clin Chim Acta; 1988 Sep; 177(1):77-80. PubMed ID: 2460272
[TBL] [Abstract][Full Text] [Related]
9. Is acid phosphatase (PAP) still justified in the management of prostatic cancer?
Kontturi M
Acta Oncol; 1991; 30(2):169-70. PubMed ID: 1709356
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of the serum concentration of prostate-specific antigen as a biological marker in the evolution of disseminated prostatic cancer].
Morote Robles J; de Torres Mateos JA; Soler-Roselló A
Actas Urol Esp; 1988; 12(2):152-7. PubMed ID: 2458015
[No Abstract] [Full Text] [Related]
11. Immunologic markers and the diagnosis of prostatic cancer.
Ban Y; Wang MC; Chu TM
Urol Clin North Am; 1984 May; 11(2):269-76. PubMed ID: 6203206
[TBL] [Abstract][Full Text] [Related]
12. Experience with prostate-specific antigen in prostatic carcinoma.
Romics I; Bach D
Int Urol Nephrol; 1991; 23(5):465-72. PubMed ID: 1718923
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of prostate specific acid phosphatase and prostate specific antigen in identification of prostatic cancer.
Allhoff EP; Proppe KH; Chapman CM; Lin CW; Prout GR
J Urol; 1983 Feb; 129(2):315-8. PubMed ID: 6339742
[TBL] [Abstract][Full Text] [Related]
14. New developments in biological markers in prostate cancer.
Pontes JE
Recent Results Cancer Res; 1990; 118():186-9. PubMed ID: 1700455
[No Abstract] [Full Text] [Related]
15. The relation of prostatic acid phosphatase and prostate specific antigen with tumour grade in prostatic adenocarcinoma: an immunohistochemical study.
Ersev A; Ersev D; Turkeri L; Ilker Y; Simsek F; Kullu S; Akdas A
Prog Clin Biol Res; 1990; 357():129-34. PubMed ID: 1699237
[TBL] [Abstract][Full Text] [Related]
16. [A case of mucinous adenocarcinoma of the prostate].
Ezura M; Kimura N; Nagura H
Gan No Rinsho; 1990 Mar; 36(4):563-6. PubMed ID: 1690826
[TBL] [Abstract][Full Text] [Related]
17. Prostate specific acid phosphatase versus five other possible tumour markers: a comparative study in men with prostatic carcinoma.
Larson A; Fritjofsson A; Norlén BJ; Gronowitz JS; Ronquist G
Scand J Clin Lab Invest Suppl; 1985; 179():81-8. PubMed ID: 2417306
[No Abstract] [Full Text] [Related]
18. Histochemistry and quantitative microscopy of prostate cancer.
Bennett BD
Prog Clin Biol Res; 1987; 239():711-58. PubMed ID: 2443917
[No Abstract] [Full Text] [Related]
19. [Clinical studies on tumor markers for monitoring prostate cancer patients; the evaluation of prostate-specific antigen and comparison with prostatic acid phosphatase and gamma-seminoprotein].
Shinoda I
Nihon Gan Chiryo Gakkai Shi; 1990 Nov; 25(11):2627-39. PubMed ID: 1703555
[TBL] [Abstract][Full Text] [Related]
20. Role of immunocytochemistry in diagnosis of prostatic neoplasia by fine needle aspiration biopsy.
Katz RL; Raval P; Brooks TE; Ordóñez NG
Diagn Cytopathol; 1985; 1(1):28-32. PubMed ID: 2424683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
